These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30121639)

  • 21. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis.
    Liu H; Li W; Yu X; Gao F; Duan Z; Ma X; Tan S; Yuan Y; Liu L; Wang J; Zhou X; Yang Y
    Oncotarget; 2016 Aug; 7(35):56338-56354. PubMed ID: 27472460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.
    Ren T; Shan J; Qing Y; Qian C; Li Q; Lu G; Li M; Li C; Peng Y; Luo H; Zhang S; Zhang W; Wang D; Zhou SF
    Drug Des Devel Ther; 2014; 8():2517-29. PubMed ID: 25548514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High expression of MYH9 inhibits apoptosis of non-small cell lung cancer cells through activating the AKT/c-Myc pathway].
    Liu F; Peng L; Xi J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):527-536. PubMed ID: 37202187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpressed D2 Dopamine Receptor Inhibits Non-Small Cell Lung Cancer Progression through Inhibiting NF-κB Signaling Pathway.
    Wu XY; Zhang CX; Deng LC; Xiao J; Yuan X; Zhang B; Hou ZB; Sheng ZH; Sun L; Jiang QC; Zhao W
    Cell Physiol Biochem; 2018; 48(6):2258-2272. PubMed ID: 30114693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.
    Li J; Viallet J; Haura EB
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):525-34. PubMed ID: 17505826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
    Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK
    J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage migration inhibitory factor limits activation-induced apoptosis of platelets via CXCR7-dependent Akt signaling.
    Chatterjee M; Borst O; Walker B; Fotinos A; Vogel S; Seizer P; Mack A; Alampour-Rajabi S; Rath D; Geisler T; Lang F; Langer HF; Bernhagen J; Gawaz M
    Circ Res; 2014 Nov; 115(11):939-49. PubMed ID: 25266363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY; Oh SH; Suh YA; Baek JH; Papadimitrakopoulou V; Huang S; Hong WK
    Clin Cancer Res; 2005 Aug; 11(16):6065-74. PubMed ID: 16115952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of cytoplasmic p27 expression with an unfavorable response to cisplatin-based chemotherapy and poor outcomes in non-small cell lung cancer.
    Lin TC; Tsai LH; Chou MC; Chen CY; Lee H
    Tumour Biol; 2016 Mar; 37(3):4017-23. PubMed ID: 26482622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of ERK1/2 and Akt is associated with cisplatin resistance in human lung cancer cells.
    Wang M; Liu ZM; Li XC; Yao YT; Yin ZX
    J Chemother; 2013 Jun; 25(3):162-9. PubMed ID: 23783141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of RIF1 on response of non-small-cell lung cancer patients to platinum-based chemotherapy by regulating MYC signaling pathway.
    Mei Y; Liu YB; Hu DL; Zhou HH
    Int J Biol Sci; 2018; 14(13):1859-1872. PubMed ID: 30443189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer.
    Shen L; Yang M; Lin Q; Zhang Z; Miao C; Zhu B
    Oncol Rep; 2016 May; 35(5):2561-8. PubMed ID: 26985856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathway.
    Liu Y; Jiang ZY; Zhou YL; Qiu HH; Wang G; Luo Y; Liu JB; Liu XW; Bu WQ; Song J; Cui L; Jia XB; Feng L
    Biomed Pharmacother; 2017 Sep; 93():490-497. PubMed ID: 28672279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling.
    Wang N; Song L; Xu Y; Zhang L; Wu Y; Guo J; Ji W; Li L; Zhao J; Zhang X; Zhan L
    EBioMedicine; 2019 Sep; 47():65-77. PubMed ID: 31495720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safflower polysaccharide induces NSCLC cell apoptosis by inhibition of the Akt pathway.
    Li JY; Yu J; Du XS; Zhang HM; Wang B; Guo H; Bai J; Wang JH; Liu A; Wang YL
    Oncol Rep; 2016 Jul; 36(1):147-54. PubMed ID: 27177149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deoxyshikonin inhibits cisplatin resistance of non-small-cell lung cancer cells by repressing Akt-mediated ABCB1 expression and function.
    Zhang S; Wang Y
    J Biochem Mol Toxicol; 2020 Oct; 34(10):e22560. PubMed ID: 32627280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.